UCB Japan
UCB Pharma operates as a biopharmaceutical company with a focus on neurology and immunology diseases. The company leverages scientific advances and skills in areas such as genetics, biomarkers, and human biology.
Last updated on
About UCB Japan
Founded
1928Estimated Revenue
$1B-$10BEmployees
10K-50KFunding / Mkt. Cap
$202MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
28NAICs Code
32Location
City
NishishinjukuState
TokyoCountry
JapanTech Stack (162)
